Published in Int J Cancer on November 09, 2010
Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia without colposcopic tissue information; a step toward automation for low resource settings. J Biomed Opt (2012) 0.93
Optical technologies and molecular imaging for cervical neoplasia: a program project update. Gend Med (2011) 0.85
Detecting high-grade squamous intraepithelial lesions in the cervix with quantitative spectroscopy and per-patient normalization. Biomed Opt Express (2011) 0.79
The use of optical spectroscopy for in vivo detection of cervical pre-cancer. Lasers Med Sci (2013) 0.79
Repeatability of tissue fluorescence measurements for the detection of cervical intraepithelial neoplasia. Biomed Opt Express (2010) 0.78
Classifying tissue samples from measurements on cells with within-class tissue sample heterogeneity. Biostatistics (2011) 0.77
Physician attitudes toward dissemination of optical spectroscopy devices for cervical cancer control: an industrial-academic collaborative study. Gend Med (2012) 0.76
Prediction using hierarchical data: Applications for automated detection of cervical cancer. Stat Anal Data Min (2015) 0.75
Early detection of high-grade squamous intraepithelial lesions in the cervix with quantitative spectroscopic imaging. J Biomed Opt (2013) 0.75
Comparison between performance of single-fiber reflectance spectroscopy (SFRS) system and colposcopy: a phase III trial. Lasers Med Sci (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
HPV screening for cervical cancer in rural India. N Engl J Med (2009) 14.13
Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer (2004) 6.99
Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85. Br Med J (Clin Res Ed) (1988) 4.60
A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol (2008) 4.43
2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol (2007) 2.97
Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA (1994) 2.71
Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting. Am J Epidemiol (2008) 2.61
Reflectance spectroscopy for in vivo detection of cervical precancer. J Biomed Opt (2002) 2.10
Trimodal spectroscopy for the detection and characterization of cervical precancers in vivo. Am J Obstet Gynecol (2002) 2.02
Autofluorescence microscopy of fresh cervical-tissue sections reveals alterations in tissue biochemistry with dysplasia. Photochem Photobiol (2001) 1.98
Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA content, and chromatin texture. J Biomed Opt (2003) 1.96
Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol (2001) 1.93
Understanding the contributions of NADH and collagen to cervical tissue fluorescence spectra: modeling, measurements, and implications. J Biomed Opt (2001) 1.88
Microanatomical and biochemical origins of normal and precancerous cervical autofluorescence using laser-scanning fluorescence confocal microscopy. Photochem Photobiol (2003) 1.69
Combined reflectance and fluorescence spectroscopy for in vivo detection of cervical pre-cancer. J Biomed Opt (2005) 1.56
Spectroscopic imaging as a triage test for cervical disease: a prospective multicenter clinical trial. J Low Genit Tract Dis (2007) 1.52
Analytical model to describe fluorescence spectra of normal and preneoplastic epithelial tissue: comparison with Monte Carlo simulations and clinical measurements. J Biomed Opt (2004) 1.46
Optical spectroscopy for detection of neoplasia. Curr Opin Chem Biol (2002) 1.45
Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine (2005) 1.43
Optimal excitation wavelengths for discrimination of cervical neoplasia. IEEE Trans Biomed Eng (2002) 1.42
Light scattering from collagen fiber networks: micro-optical properties of normal and neoplastic stroma. Biophys J (2007) 1.42
Low Temperature Fluorescence Imaging of Freeze-trapped Human Cervical Tissues. Opt Express (2001) 1.38
Fluorescence and reflectance device variability throughout the progression of a phase II clinical trial to detect and screen for cervical neoplasia using a fiber optic probe. J Biomed Opt (2007) 1.33
Model-based analysis of clinical fluorescence spectroscopy for in vivo detection of cervical intraepithelial dysplasia. J Biomed Opt (2006) 1.26
A bayesian hierarchical model for classification with selection of functional predictors. Biometrics (2009) 1.26
Effective cervical neoplasia detection with a novel optical detection system: a randomized trial. Gynecol Oncol (2006) 1.23
Development of a multivariate statistical algorithm to analyze human cervical tissue fluorescence spectra acquired in vivo. Lasers Surg Med (1996) 1.23
A clinical study of optical biopsy of the uterine cervix using a multispectral imaging system. Gynecol Oncol (2005) 1.19
Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: qualitative histopathologic analysis and methodologic issues. Gynecol Oncol (2005) 1.19
Spatially resolved reflectance spectroscopy for diagnosis of cervical precancer: Monte Carlo modeling and comparison to clinical measurements. J Biomed Opt (2007) 1.19
Autofluorescence patterns in short-term cultures of normal cervical tissue. Photochem Photobiol (2000) 1.19
In vivo light scattering measurements for detection of precancerous conditions of the cervix. Gynecol Oncol (2007) 1.18
Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study. Am J Obstet Gynecol (2004) 1.17
Spectroscopic diagnosis of cervical intraepithelial neoplasia (CIN) in vivo using laser-induced fluorescence spectra at multiple excitation wavelengths. Lasers Surg Med (1996) 1.13
Effect of probe pressure on cervical fluorescence spectroscopy measurements. J Biomed Opt (2004) 1.13
Optical imaging of the cervix. Cancer (2003) 1.12
Identification of cervical intraepithelial neoplasia (CIN) using UV-excited fluorescence and diffuse-reflectance tissue spectroscopy. Lasers Surg Med (2001) 1.12
Fluorescence spectroscopy for diagnosis of squamous intraepithelial lesions of the cervix. Obstet Gynecol (1999) 1.07
Cervical cancer in the developing world. West J Med (2001) 1.07
Fluorescence spectroscopy: a diagnostic tool for cervical intraepithelial neoplasia (CIN). Gynecol Oncol (1994) 1.05
Multimodal hyperspectral imaging for the noninvasive diagnosis of cervical neoplasia. J Low Genit Tract Dis (2001) 1.00
Model-based analysis of reflectance and fluorescence spectra for in vivo detection of cervical dysplasia and cancer. J Biomed Opt (2009) 0.99
The performance of fluorescence and reflectance spectroscopy for the in vivo diagnosis of cervical neoplasia; point probe versus multispectral approaches. Gynecol Oncol (2007) 0.98
The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we? Gynecol Oncol (2007) 0.97
Automated image analysis of digital colposcopy for the detection of cervical neoplasia. J Biomed Opt (2008) 0.96
Participant recruitment and motivation for participation in optical technology for cervical cancer screening research trials. Gynecol Oncol (2005) 0.96
Multispectral digital colposcopy for in vivo detection of cervical cancer. Opt Express (2003) 0.94
The effects of repeated spectroscopic pressure measurements on fluorescence intensity in the cervix. Am J Obstet Gynecol (2004) 0.94
Screening for squamous intraepithelial lesions with fluorescence spectroscopy. Obstet Gynecol (1999) 0.93
Detecting the signal of the menstrual cycle in fluorescence spectroscopy of the cervix. Appl Spectrosc (2003) 0.92
Calibration standards for multicenter clinical trials of fluorescence spectroscopy for in vivo diagnosis. J Biomed Opt (2006) 0.91
Effects of biographical variables on cervical fluorescence emission spectra. J Biomed Opt (2003) 0.91
Absolute quantitative real-time polymerase chain reaction for the measurement of human papillomavirus E7 mRNA in cervical cytobrush specimens. Infect Agent Cancer (2007) 0.90
Maximizing the diversity of participants in a phase II clinical trial of optical technologies to detect cervical neoplasia. Gynecol Oncol (2007) 0.89
Fluorescence spectroscopy for cervical precancer detection: Is there variance across the menstrual cycle? J Biomed Opt (2002) 0.89
Safety analysis: relative risks of ultraviolet exposure from fluorescence spectroscopy and colposcopy are comparable. Photochem Photobiol (1997) 0.87
Technology assessment in medicine. Acad Med (1992) 0.86
Methodology of a real-time quality control for the multispectral digital colposcope (MDC). Gynecol Oncol (2007) 0.86
Autofluorescence spectroscopy for the diagnosis of cervical intraepithelial neoplasia. BJOG (2002) 0.85
Instrumentation as a source of variability in the application of fluorescence spectroscopic devices for detecting cervical neoplasia. J Biomed Opt (2007) 0.85
Design and preliminary analysis of a study to assess intra-device and inter-device variability of fluorescence spectroscopy instruments for detecting cervical neoplasia. Gynecol Oncol (2005) 0.85
An electronic approach to the detection of pre-cancer and cancer of the uterine cervix: a preliminary evaluation of Polarprobe. Int J Gynecol Cancer (1994) 0.84
A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: a multicenter evaluation. Int J Gynecol Cancer (2003) 0.84
Cost-effectiveness analysis of diagnosis and management of cervical squamous intraepithelial lesions. Obstet Gynecol (1998) 0.83
Patient distress and satisfaction with optical spectroscopy in cervical dysplasia detection. Am J Obstet Gynecol (2003) 0.81
The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings. Cancer Epidemiol Biomarkers Prev (2008) 0.81
Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies. Gend Med (2012) 0.81
Identification of squamous intraepithelial lesions: fluorescence of cervical tissue during colposcopy. J Low Genit Tract Dis (1999) 0.80
Results of a pilot study of multispectral digital colposcopy for the in vivo detection of cervical intraepithelial neoplasia. Gynecol Oncol (2005) 0.80
Hyperspectral diagnostic imaging of the cervix: report on a new investigational device. J Low Genit Tract Dis (2000) 0.79
Variation of fluorescence spectroscopy during the menstrual cycle. Opt Express (2002) 0.79
The accuracy of the Papanicolaou smear in the screening and diagnostic settings. J Low Genit Tract Dis (2008) 0.77
A quality-control program for colposcopic practice. Obstet Gynecol (1991) 0.76
Initial neural net construction for the detection of cervical intraepithelial neoplasia by fluorescence imaging. Am J Obstet Gynecol (2002) 0.76
ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med (2010) 13.07
Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med (2009) 5.63
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med (2008) 5.19
Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res (2003) 4.22
Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer (2008) 3.98
Resolving the resolution of array CGH. Genomics (2007) 3.66
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA (2013) 3.06
Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate? J Clin Oncol (2007) 2.96
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res (2002) 2.71
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res (2006) 2.24
EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens. Cancer Cytopathol (2011) 2.19
Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst (2009) 2.17
Reflectance spectroscopy for in vivo detection of cervical precancer. J Biomed Opt (2002) 2.10
Neoadjuvant chemotherapy is associated with prolonged primary treatment intervals in patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer (2011) 2.02
Measuring the prevalence of overweight in Texas schoolchildren. Am J Public Health (2004) 1.97
Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA content, and chromatin texture. J Biomed Opt (2003) 1.96
Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms. Am J Surg Pathol (2005) 1.94
Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstet Gynecol (2006) 1.93
Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo. J Biomed Opt (2007) 1.90
Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol (2007) 1.85
Near real-time confocal microscopy of amelanotic tissue: detection of dysplasia in ex vivo cervical tissue. Acad Radiol (2002) 1.84
In vivo fiber-optic confocal reflectance microscope with an injection-molded plastic miniature objective lens. Appl Opt (2005) 1.83
A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med (2010) 1.81
The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol (2006) 1.79
Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res (2010) 1.77
A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC). Cancer Inform (2007) 1.76
A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium. Clin Cancer Res (2004) 1.73
The "Safer Choices" intervention: its impact on the sexual behaviors of different subgroups of high school students. J Adolesc Health (2004) 1.73
Exploring the potential of Web 2.0 to address health disparities. J Health Commun (2011) 1.72
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol (2003) 1.72
Microanatomical and biochemical origins of normal and precancerous cervical autofluorescence using laser-scanning fluorescence confocal microscopy. Photochem Photobiol (2003) 1.69
Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol (2007) 1.69
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res (2008) 1.68
A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Pediatr Blood Cancer (2011) 1.68
Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer. Histopathology (2012) 1.64
Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level. Int J Gynecol Pathol (2004) 1.62
Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol (2009) 1.62
Tissue macroarray: a simple and cost-effective method for high-throughput studies. Appl Immunohistochem Mol Morphol (2003) 1.61
Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res (2002) 1.61
Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. Int J Radiat Oncol Biol Phys (2006) 1.61
The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer (2009) 1.60
Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck (2007) 1.58
Quantitative histopathological analysis of cervical intra-epithelial neoplasia sections: methodological issues. Cell Oncol (2004) 1.58
Combined reflectance and fluorescence spectroscopy for in vivo detection of cervical pre-cancer. J Biomed Opt (2005) 1.56
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res (2003) 1.55
Contrast agents for confocal microscopy: how simple chemicals affect confocal images of normal and cancer cells in suspension. J Biomed Opt (2002) 1.53
Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol (2006) 1.52
An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol (2004) 1.52
Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev (2009) 1.51
A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst (2002) 1.50
Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps. Am J Surg Pathol (2005) 1.49
An exploratory case-only analysis of gene-hazardous air pollutant interactions and the risk of childhood medulloblastoma. Pediatr Blood Cancer (2012) 1.49
Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment. Cell Cycle (2010) 1.48
Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy. Cancer Epidemiol Biomarkers Prev (2013) 1.47
Objective assessment of aesthetic outcomes of breast cancer treatment: measuring ptosis from clinical photographs. Comput Biol Med (2006) 1.47
Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change? Int J Gynecol Pathol (2010) 1.47
Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV. Gynecol Oncol (2005) 1.47
Analytical model to describe fluorescence spectra of normal and preneoplastic epithelial tissue: comparison with Monte Carlo simulations and clinical measurements. J Biomed Opt (2004) 1.46
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas. Am J Pathol (2010) 1.46
Optical spectroscopy for detection of neoplasia. Curr Opin Chem Biol (2002) 1.45
Using intervention mapping to adapt an effective HIV, sexually transmitted disease, and pregnancy prevention program for high-risk minority youth. Health Promot Pract (2005) 1.45
An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms. Am J Surg Pathol (2005) 1.43
Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems. Am J Surg Pathol (2005) 1.42
Optimal excitation wavelengths for discrimination of cervical neoplasia. IEEE Trans Biomed Eng (2002) 1.42
Communicating colposcopy results: what do patients and providers discuss? J Low Genit Tract Dis (2008) 1.42
Care of the pregnant patient with cancer. Oncology (Williston Park) (2008) 1.41
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work. Med Care (2015) 1.41
Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma. PLoS Med (2010) 1.38
Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy. Clin Cancer Res (2010) 1.38
Lymphangioma circumscriptum of the vulva: a review of the literature. Obstet Gynecol (2003) 1.38
Undifferentiated carcinoma of the endometrium: a review. Pathology (2007) 1.38
Primary retroperitoneal mucinous tumors: a clinicopathologic study of 18 cases. Am J Surg Pathol (2009) 1.36
Sources of scattering in cervical tissue: determination of the scattering coefficient by confocal microscopy. Appl Opt (2005) 1.35
Fluorescence and reflectance device variability throughout the progression of a phase II clinical trial to detect and screen for cervical neoplasia using a fiber optic probe. J Biomed Opt (2007) 1.33
Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study. Cancer (2011) 1.33